Bioplus Life Sciences

Bioplus, Pioneering life-saving science for a healthier future Bioplus Life Sciences is a leading biopharmaceutical company with over 75 years of experience serving the pharmaceutical industry. Building on a strong foundation of high-quality products, services, and technology in contract manufacturing and generic pharmaceuticals, Bioplus today is a late-stage clinical phase company focused on developing novel therapeutics to address significant global unmet needs. The company has two clinical phase-3 ready programs and a rich pipeline of pre-clinical candidates, targeting global blockbuster potential. Additionally, we maintain a robust pipeline of pre-clinical programs, positioning us for significant growth over the next five years as our groundbreaking novel therapeutics enter the market. Bioplus intends to partner with leading regional and global companies to optimize product market access. Notably, it is the only company in India to have successfully commercialized microalgal fermentation for Omega-3 fatty acids. A pioneer in advanced fermentation biotechnology, Bioplus holds over 40 patents and possesses more than 15 years of expertise. Complementing this expertise, Bioplus operates a state-of-the-art synthetic biology lab dedicated to the development of innovative recombinant proteins, peptides, and pharmaceutical ingredients. With over 14 drug candidates in development and established partnerships with leading universities across India, the USA, and Europe, Bioplus remains committed to cutting-edge research and development. The company is significantly investing in R&D, clinical development, and CAPEX for capacity and capability expansion, anticipating significant growth over the next 5 years as its novel therapeutics reach the market. Bioplus is driven by scientific curiosity, focused on targeted clinical development, and dedicated to contributing to the health and well-being of global citizens. Innovate, Explore, Develop